Citations

Clear

3942 citation(s) found for "To, Van".

O2‐04‐05: CSF BIOMARKERS IN THE GENERAL POPULATION: ASSOCIATIONS WITH DEMOGRAPHICS AND APOE GENOTYPE
Wiste, Heather J. , Weigand, Stephen D. , Eichenlaub, Udo, Batrla‐Utermann, Richard, Petersen, Ronald C. , Harten, Argonde C. van , Mielke, Michelle M. , Kremers, Walter K. , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2018.06.2661 Get It

F2‐02‐01: NEUROFILAMENT LIGHT CHAIN IN AD IN CSF AND BLOOD
Syrjanen, Jeremy A. , Blennow, Kaj , Hagen, Clinton E., Petersen, Ronald C. , Kern, Silke , Zetterberg, Henrik , Skoog, Ingmar , Wærn, Margda , Harten, Argonde C. van , Knopman, David S. , Jack, Clifford R. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2018.06.2615 Get It

P2‐273: CEREBROSPINAL FLUID NEUROFILAMENT LIGHT PROTEIN AND RISK OF MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY OF AGING
Syrjanen, Jeremy A. , Blennow, Kaj , Hagen, Clinton E., Petersen, Ronald C. , Kern, Silke , Zetterberg, Henrik , Skoog, Ingmar , Wærn, Margda , Harten, Argonde C. van , Knopman, David S. , Jack, Clifford R. , Mielke, Michelle M.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2018.06.962 Get It

P1‐256: COMMUNICATION ON DIAGNOSTIC TESTING FOR (ALZHEIMER'S) DEMENTIA: THE ABIDE‐CLINICAL ENCOUNTER STUDY
Kunneman, Marleen , Visser, Leonie N.C. , Murugesu, Laxsini , Bouwman, Femke H. , Flier, Wiesje M. van der , Smets, Ellen M.A.

Mayo Clinic

Alzheimer's & Dementia | October 22, 2018 | Volume: 14 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2018.06.262 Get It

UIAA Medical Commission Recommendations for Mountaineers, Hillwalkers, Trekkers, and Rock and Ice Climbers with Diabetes
Hillebrandt, David , Gurtoo, Anil, Spek, Rianne van der , Wallis, Nikki, Milledge, Jim, Küpper, Thomas , Richards, Paul, Schöffl, Volker , Shah, Pankaj

Mayo Clinic

High Altitude Medicine & Biology | October 18, 2018 | Volume: 24 | Issue: 2 | Pages: 110-126

10.1089/ham.2018.0043 | PMID 30335516 Get It

Hillebrandt, David, Anil Gurtoo, Thomas Kupper, Paul Richards, Volker Schöffl, Pankaj Shah, Rianne van der Spek, Nikki Wallis, and Jim Milledge. UIAA Medical Commission recommendations for mountaineers, hillwalkers, trekkers, and rock and ice climbers with diabetes. High Alt Med Biol . 24: 110–126.—The object of this advice article is not only to give the diabetic mountaineer general guidance but also to inform his or her medical team of practical aspects of care that may not be standard for nonmountaineers. The guidelines are produced in seven sections. The first is an introduction to the guidelines, and the second is an introduction to this medical problem and is designed to be read and understood by diabetic patients and their companions. The third section is for use in an emergency in mountains. The fourth is for rock, ice, and competition climbers operating in a less remote environment. These initial sections are deliberately written in simple language. The fifth and sixth sections are written for clinicians and those with skills to read more technical information, and the seventh looks at modern technology and its pros and cons in diabetes management in a remote area. Sections One and Two could be laminated and carried when in the mountains, giving practical advice.
Standard Operating Procedures for Biospecimen Collection, Processing, and Storage
Fisher, William E., Cruz‐Monserrate, Zobeida , McElhany, Amy L., Hart, Phil A. , Ghosh, Ria , Buren, George Van , Fishman, Douglas S., Rinaudo, Jo Ann, Serrano, José , Srivastava, Sudhir , Mace, Thomas A. , Topazian, Mark , Feng, Ziding , Yadav, Dhiraj , Hughes, Steven J. , Liu, Robert Y., Lu, Emily Y., Orr, Robert Scott, Abouhamze, Amer, Troendle, David M. , Uç, Aliye , Lowe, Mark E. , Conwell, Darwin L. , Whitcomb, David C. , Serrano, Jose , Lesinski, Gregory B , Ghosh, Ria, Pandol, Stephen J. , Orr, Robert, Steen, Hanno , Sellers, Zachary M.

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1213-1221

10.1097/mpa.0000000000001171 | PMID 30325860 Get It

Abstract High-quality and well-annotated biorepositories are needed to better understand the pathophysiology and biologic mechanisms of chronic pancreatitis (CP) and its consequences. We report a methodology for the development of a robust standard operating procedure (SOP) for a biorepository based on the experience of the clinical centers within the consortium to study Chronic Pancreatitis, Diabetes and Pancreas Cancer Clinical Centers (CPDPC), supported by the National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases as a unique multidisciplinary model to study CP, diabetes, and pancreatic cancer in both children and adults. Standard operating procedures from the CPDPC centers were evaluated and consolidated. The literature was reviewed for standard biorepository operating procedures that facilitated downstream molecular analysis. The existing literature on biobanking practices was harmonized with the SOPs from the clinical centers to produce a biorepository for pancreatic research. This article reports the methods and basic principles behind the creation of SOPs to develop a biorepository for the CPDPC. These will serve as a guide for investigators developing biorepositories in pancreas research. Rigorous and meticulous adherence to standardized biospecimen collection will facilitate investigations to better understand the pathophysiology and biologic mechanisms of CP, diabetes, and pancreatic cancer.
PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies
Yadav, Dhiraj , Park, Walter G. , Fogel, Evan L. , Li, Liang , Chari, Suresh T. , Feng, Ziding , Fisher, William E., Forsmark, Christopher E., Habtezion, Aida , Hart, Phil A. , Hughes, Steven J. , Othman, Mohamed O. , Rinaudo, Jo Ann, Serrano, José , Srivastava, Sudhir , Topazian, Mark , Conwell, Darwin L. , Serrano, Jose , Jeon, Christie Y. , Pandol, Stephen J. , Tirkes, Temel , Van Den Eeden, Stephen K , Whitcomb, David C. , Chari, Suresh T

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1229-1238

10.1097/mpa.0000000000001170 | PMID 30325862 Get It

Abstract Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) is the first prospective, observational cohort study of chronic pancreatitis (CP) in the United States. The primary goals of PROCEED are to define disease progression, test the predictive capability of candidate biomarkers, and develop a platform to conduct translational and mechanistic studies in CP. Using objective and consensus-driven criteria, PROCEED will enroll adults at different stages of CP—controls, suspected CP, and definite CP. In addition to collecting detailed information using structured case report forms and protocol-mandated evaluations at baseline and during follow-up, PROCEED will establish a linked biorepository of blood, urine, saliva, stool, pancreatic fluid, and pancreatic tissue. Enrollment for PROCEED began in June 2017. As of July 1, 2018, nine clinical centers of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer are enrolling, and 350 subjects have completed baseline evaluation. In conclusion, PROCEED will provide the most accurate and reliable estimates to date on progression of CP. The established cohort and biorepository will facilitate numerous analyses, leading to new strategies for diagnosis, methods to monitor disease progression, and treatment of CP.
A Prospective Study to Establish a New-Onset Diabetes Cohort
Sharma, Ayush , Fisher, William E., Hart, Phil A. , Hughes, Steven J. , Mather, Kieren J., Park, Walter G. , Feng, Ziding , Serrano, José , Rinaudo, Jo Ann, Srivastava, Sudhir , Chari, Suresh T. , Serrano, Jose , Maitra, Anirban , Brand, Randall E. , Van Den Eeden, Stephen K , Pandol, Stephen J. , Chari, Suresh T

Mayo Clinic

Pancreas | October 16, 2018 | Volume: 47 | Issue: 10 | Pages: 1244-1248

10.1097/mpa.0000000000001169 | PMID 30325864 Get It

Abstract The National Cancer Institute and the National Institute for Diabetes and Digestive and Kidney Diseases initiated the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) in 2015 (the CPDPC's origin, structure, governance, and research objectives are described in another article in this journal). One of the key objectives of CPDPC is to assemble a cohort of 10,000 subjects 50 years or older with new-onset diabetes, called the NOD cohort. Using a define, enrich, and find early detection approach, the aims of the NOD study are to ( a ) estimate the 3-year probability of pancreatic ductal adenocarcinoma (PDAC) in NOD ( define ), (b) establish a biobank of clinically annotated biospecimens from presymptomatic PDAC and control new-onset type 2 diabetes mellitus subjects, (c) conduct phase 3 validation studies of promising biomarkers for identification of incident PDAC in NOD patients ( enrich ), and (d) provide a platform for development of a future interventional screening protocol for early detection of PDAC in patients with NOD that incorporates imaging studies and/or clinical algorithms ( find ). It is expected that 85 to 100 incidences of PDAC will be diagnosed during the study period in this cohort of 10,000 patients.